Inhibition of Release of Inflammatory Mediators in Primary and Cultured Cells by a Chinese Herbal Medicine Formula for Allergic Rhinitis

Overview

Journal Chin Med

Publisher Biomed Central

Specialty Biomedical Engineering

Date 2007 Feb 17

PMID 17302969

Citations 7

Authors

George B Lenon

Charlie C L Xue

David F Story

Frank C K Thien

Sarah McPhee

Chun G Li

Affiliations

Soon will be listed here.

Abstract

Background: We demonstrated that a Chinese herbal formula, which we refer to as RCM-101, developed from a traditional Chinese medicine formula, reduced nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR). The present study in primary and cultured cells was undertaken to investigate the effects of RCM-101 on the production/release of inflammatory mediators known to be involved in SAR.

Methods: Compound 48/80-induced histamine release was studied in rat peritoneal mast cells. Production of leukotriene B4 induced by the calcium ionophore A23187 was studied in porcine neutrophils using an HPLC assay and lipopolysaccharide-stimulated prostaglandin E2 production was studied in murine macrophage (Raw 264.7) cells by immune-enzyme assay. Expression of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) was determined in Raw 264.7 cells, using western blotting techniques.

Results: RCM-101 (1-100 microg/mL) produced concentration-dependent inhibition of compound 48/80-induced histamine release from rat peritoneal mast cells and of lipopolysaccharide-stimulated prostaglandin E2 release from Raw 264.7 cells. Over the range 1-10 microg/mL, it inhibited A23187-induced leukotriene B4 production in porcine neutrophils. In addition, RCM-101 (100 microg/mL) inhibited the expression of COX-2 protein but did not affect that of COX-1.

Conclusion: The findings indicate that RCM-101 inhibits the release and/or synthesis of histamine, leukotriene B4 and prostaglandin E2 in cultured cells. These interactions of RCM-101 with multiple inflammatory mediators are likely to be related to its ability to reduce symptoms of allergic rhinitis.

Citing Articles

The Effects of Aqueous Extracts on the Inflammation and Intestinal Microflora in Allergic Rhinitis Mice.

Chen Y, Chen Z, Wang G, Xu S Evid Based Complement Alternat Med. 2022; 2022:1052359.

PMID: 36276863 PMC: 9586736. DOI: 10.1155/2022/1052359.

Dereplication Based Strategy for Rapid Identification and Isolation of a Novel Anti-inflammatory Flavonoid by LCMS/MS from .

Sharma N, Khajuria V, Gupta S, Kumar C, Sharma A, Lone N ACS Omega. 2021; 6(45):30241-30259.

PMID: 34805658 PMC: 8600527. DOI: 10.1021/acsomega.1c01837.

constituent fargesin has an anti-allergic effect ORAI1 channel inhibition.

Hong P, Kim H, Kim W, Nam J Korean J Physiol Pharmacol. 2021; 25(3):251-258.

PMID: 33859065 PMC: 8050608. DOI: 10.4196/kjpp.2021.25.3.251.

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Wise S, Lin S, Toskala E, Orlandi R, Akdis C, Alt J Int Forum Allergy Rhinol. 2018; 8(2):108-352.

PMID: 29438602 PMC: 7286723. DOI: 10.1002/alr.22073.

Complementary therapies in allergic rhinitis.

Sayin I, Cingi C, Oghan F, Baykal B, Ulusoy S ISRN Allergy. 2013; 2013:938751.

PMID: 24324897 PMC: 3845706. DOI: 10.1155/2013/938751.

References

Naclerio R . Allergic rhinitis. N Engl J Med. 1991; 325(12):860-9. DOI: 10.1056/NEJM199109193251206. View

Bachert C, Bousquet J, Canonica G, Durham S, Klimek L, Mullol J . Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004; 114(4):838-44. DOI: 10.1016/j.jaci.2004.05.070. View

Lee Y, Hirota S, Kim H, Shin T, Yeom Y, Lee K . Inhibition of histamine synthesis by glycyrrhetinic acid in mast cells cocultured with Swiss 3T3 fibroblasts. Int Arch Allergy Immunol. 1996; 110(3):272-7. DOI: 10.1159/000237298. View

Inoue H, Saito H, Koshihara Y, Murota S . Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase. Chem Pharm Bull (Tokyo). 1986; 34(2):897-901. DOI: 10.1248/cpb.34.897. View

Kim H, Yi J, Lim K . Magnoliae flos inhibits mast cell-dependent immediate-type allergic reactions. Pharmacol Res. 1999; 39(2):107-11. DOI: 10.1006/phrs.1998.0414. View

Betts W, Hurst N, Murphy G, Cleland L . Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem Pharmacol. 1990; 39(7):1233-7. DOI: 10.1016/0006-2952(90)90268-p. View

Passalacqua G, Bousquet P, Carlsen K, Kemp J, Lockey R, Niggemann B . ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006; 117(5):1054-62. DOI: 10.1016/j.jaci.2005.12.1308. View

Hwang B, Lee J, Koo T, Kim H, Hong Y, Ro J . Furanoligularenone, an eremophilane from Ligularia fischeri, inhibits the LPS-induced production of nitric oxide and prostaglandin E2 in macrophage RAW264.7 cells. Planta Med. 2002; 68(2):101-5. DOI: 10.1055/s-2002-20250. View

Ishiguro K, Oku H, Suitani A, Yamamoto Y . Effects of conjugated linoleic acid on anaphylaxis and allergic pruritus. Biol Pharm Bull. 2002; 25(12):1655-7. DOI: 10.1248/bpb.25.1655. View

10.

Ikarashi Y, Yuzurihara M, Sakakibara I, Takahashi A, Ishimaru H, Maruyama Y . Effects of an oriental herbal medicine, "Saiboku-to", and its constituent herbs on Compound 48/80-induced histamine release from peritoneal mast cells in rats. Phytomedicine. 2001; 8(1):8-15. DOI: 10.1078/0944-7113-00012. View

11.

Provost P, Borgeat P, Merhi Y . Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor. Br J Pharmacol. 1998; 123(2):251-8. PMC: 1565165. DOI: 10.1038/sj.bjp.0701611. View

12.

Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto Y, Tatsuno T . Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta. 1984; 792(1):92-7. View

13.

Fung D, Lau C . Schizonepeta tenuifolia: chemistry, pharmacology, and clinical applications. J Clin Pharmacol. 2002; 42(1):30-6. DOI: 10.1177/0091270002042001003. View

14.

Xue C, Thien F, Zhang J, Da Costa C, Li C . Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial. Altern Ther Health Med. 2003; 9(5):80-7. View

15.

Seo W, Pae H, Oh G, CHAI K, Kwon T, Yun Y . Inhibitory effects of methanol extract of Cyperus rotundus rhizomes on nitric oxide and superoxide productions by murine macrophage cell line, RAW 264.7 cells. J Ethnopharmacol. 2001; 76(1):59-64. DOI: 10.1016/s0378-8741(01)00221-5. View

16.

Azevedo M, Castel-Branco M, Oliveira J, Ramos E, Delgado L, Almeida J . Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy. 1991; 21(6):689-94. DOI: 10.1111/j.1365-2222.1991.tb03197.x. View

17.

Senti G, Johansen P, Martinez Gomez J, Prinz Varicka B, Kundig T . Efficacy and safety of allergen-specific immunotherapy in rhinitis, rhinoconjunctivitis, and bee/wasp venom allergies. Int Rev Immunol. 2005; 24(5-6):519-31. DOI: 10.1080/08830180500370944. View

18.

Baraniuk J . Pathogenesis of allergic rhinitis. J Allergy Clin Immunol. 1997; 99(2):S763-72. DOI: 10.1016/s0091-6749(97)70125-8. View

19.

Bousquet J, Vignola A, Demoly P . Links between rhinitis and asthma. Allergy. 2003; 58(8):691-706. DOI: 10.1034/j.1398-9995.2003.00105.x. View

20.

Salib R, Howarth P . Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf. 2003; 26(12):863-93. DOI: 10.2165/00002018-200326120-00003. View